FTO and obesity due to melanocortin 4 receptor deficiency: FTO is the first identified m6A demethylase and primarily functions to remove m6A methylation through its oxidative demethylase activity, playing critical roles in a variety of pathological conditions, including obesity, diabetes, heart failure, neurological disorders, and tumorigenesis [22–24].